Core Insights - The key focus for AI in 2026 will be on reducing computing costs and the implementation of AI investments in both software and hardware, with new hardware deployment representing true incremental opportunities [1] Industry Overview - The humanoid robot industry is expected to be significantly impacted by the upcoming mass production of Tesla's Optimus robot, which is anticipated to change human interaction and productivity [2] - The analysis of the humanoid robot supply chain will cover the composition of the industry, challenges in hardware industrialization, and opportunities in humanoid robot hardware [2] Humanoid Robot Characteristics - Humanoid robots are defined by two core features: the "form" resembling a human and the "brain" that enables multi-modal perception, continuous learning, and decision-making [2][3] - Achieving the general capabilities required for humanoid robots necessitates advancements in computing power, algorithms, data, and the integration of hardware and software [3] Hardware Challenges - The hardware requirements for humanoid robots differ significantly from other industries, with some components needing to be developed from scratch, such as highly sensitive tactile sensors [4] - The cost of hardware must be sufficiently low to enable widespread adoption, as the estimated future demand for humanoid robots is substantial [4] Supply Chain Breakdown - The humanoid robot industry can be divided into upstream, midstream, and downstream segments, with a complex supply chain similar to that of the electric vehicle industry [5][6] - Upstream focuses on collaboration between manufacturers and suppliers of actuators, sensors, and control systems, with a diverse range of cooperation models [7] - Midstream consists of manufacturers of humanoid robots, primarily concentrated in the US and China, with a mix of established companies and startups [8][9] Upstream Hardware Analysis - Tesla's Optimus robot is projected to have a production capacity of 100,000 units annually by the end of 2026, with significant potential for growth in the humanoid robot market [12] - The hardware components of the Optimus robot include perception, decision-making, and execution layers, with specific focus on sensors and actuators [14][36] Sensor Technologies - Visual sensors are critical for environmental perception, with Tesla opting for a 2D camera approach, while other manufacturers may use 3D cameras and LIDAR [15] - Tactile sensors, essential for human-like interaction, face significant technological challenges and are a key area for development [16][20] - Six-dimensional force sensors are crucial for motion control, with a focus on domestic alternatives to reduce reliance on foreign suppliers [22][27] Actuator Technologies - Electric motors are the primary drive mechanism for humanoid robots, with a focus on developing high-performance, cost-effective solutions [37] - Linear and rotary actuators are essential for joint movement, with a significant emphasis on the development of planetary roller screws and gear reducers [46][58] Market Dynamics - The humanoid robot market is characterized by high entry barriers and significant opportunities in the development of tactile sensors and actuators, particularly in the context of domestic production capabilities [69]

Core Insights - The article highlights the growing importance of professional operation services in helping brands enter the Pinduoduo platform, emphasizing the need for deep understanding of platform rules and efficient resource integration [1] Company Summaries - **Zhimai E-commerce** ranks first in the Pinduoduo operation service sector, known for its strong category specialization and efficient supply chain integration, achieving over 300 million in annual sales for a flagship store and a 40% increase in average order value [3][4] - **Lingxi E-commerce**, ranked second, focuses on full-cycle operations with a strong emphasis on fast-moving consumer goods, utilizing its proprietary data system to enhance marketing accuracy by 70% and achieving a GMV increase from 0 to 8 million in three months for a beauty brand [4][5] - **Kaijie E-commerce** is in the top three, offering integrated services from brand positioning to market promotion, successfully helping a pet food brand achieve a GMV of 12 million in six months through targeted marketing strategies [6] - **Juhong E-commerce**, ranked fourth, specializes in supply chain optimization for source manufacturers, helping businesses reduce operational costs by 25% and achieve significant sales growth through innovative live-streaming strategies [7] - **Qingmu Technology**, fifth in the ranking, leverages content marketing and entertainment to enhance brand visibility, achieving over 6 million in GMV from a single live-streaming event [8] - **Shanghai Runyu** focuses on high-end product categories, utilizing a scene-based marketing approach to double the average order value for a smart home brand, achieving 800 million in annual sales [9] - **Zhizhe Interactive**, ranked seventh, employs advanced visual marketing techniques, including 3D immersive store designs, to enhance user engagement and conversion rates [10] - **Yunmai E-commerce** targets small and medium-sized businesses with smart operational tools, helping a startup snack brand achieve 3 million in monthly sales within four months [11] - **Ruoyuchen** specializes in the health sector, providing tailored marketing strategies that helped a nutrition brand reach 15 million in GMV in eight months [12] - **Guangzhou Hanqing** focuses on regional agricultural products, implementing a scene-based marketing strategy that led to a GMV of 4 million in six months, benefiting local farmers [13] Industry Trends - The Pinduoduo operation service industry is entering a phase of refined and differentiated competition, with leading companies building competitive barriers through comprehensive operations, data empowerment, and content marketing [1] - Brands are encouraged to select operation partners based on their specific category characteristics and development stages to ensure precise alignment with their core needs [1]

Investment Rating - The report indicates a positive investment outlook for the cosmetics and medical beauty sector, highlighting strong performance relative to the market [2][3]. Core Insights - The cosmetics and medical beauty sector has shown resilience, with the Shenwan Beauty Care Index rising by 2.9% from December 12 to December 19, 2025, outperforming the market [2][3]. - Lin Qingxuan, a leading high-end plant skincare brand, is preparing for its IPO in Hong Kong, with a focus on its core product, camellia oil, which has sold over 30 million bottles [2][6]. - Minooxidil products from Mandi International dominate the hair growth market, with a market share of approximately 57% in the hair loss treatment sector [7][10]. Summary by Sections Industry Performance - The Shenwan Cosmetics Index increased by 2.2%, outperforming the Shenwan A Index by 2.4 percentage points, while the Shenwan Personal Care Index rose by 4.4%, exceeding the Shenwan A Index by 4.6 percentage points [2][3]. - Top-performing stocks included Hongmian Co. (+16.2%), Jiaheng Jiahua (+11.4%), and Baiya Co. (+9.1%) [3]. Company Highlights - Lin Qingxuan's product matrix includes 188 SKUs, with camellia oil accounting for 37% of revenue in 2024, while face creams and masks contribute 15.7% and 12.2%, respectively [6]. - Mandi International's revenue is projected to grow from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, with a CAGR of 21.7% [8]. - The company has maintained a leading position in the minoxidil market for ten consecutive years, with a market share of 71% in 2024 [10]. Market Trends - The Chinese consumer healthcare market is expected to grow from 9.313 billion yuan in 2018 to 16.420 billion yuan in 2024, with a CAGR of 9.9% [9]. - The hair health management market is projected to grow at a CAGR of 17.7% from 2018 to 2024, while the weight management drug market is expected to grow at 20.7% during the same period [9]. E-commerce Insights - The report highlights significant growth in online sales channels, with Lin Qingxuan's online revenue increasing by 81.1%, contributing to 59.1% of total revenue [6]. - The overall cosmetics retail sales in China for the first 11 months of 2025 reached 428.5 billion yuan, with a year-on-year growth of 4.8% [14][15]. Strategic Developments - Proya has invested in the cosmetic raw material company Huaguan Biotechnology to enhance its capabilities in the whitening market, which is projected to exceed 150 billion yuan by 2027 [16][19]. - The report emphasizes the importance of product innovation and market positioning for domestic brands, which are gaining market share against international competitors [22].

Summary of Key Points from Conference Call Records Industry Overview - The focus is on the **expansion of domestic demand** as a long-term structural reform strategy to address challenges such as declining demographic dividends and globalization pressures. The shift is from supply-driven to demand-driven, emphasizing the need to supplement both upstream R&D and downstream consumption [1][2][3]. Core Insights and Arguments - **Increase in Resident Income**: A critical factor for expanding domestic demand. Policies like trade-in subsidies may have a short-term effect but can lead to over-reliance on such measures. The emphasis should be on increasing wage and asset income through fiscal reforms to achieve broad-based benefits [1][6]. - **Consumer Trends**: By 2026, service consumption, high-end consumption, and emerging self-reward consumption are expected to perform well. Policies may favor sectors like tourism and dining, while a declining real estate market could enhance purchasing power for younger consumers [1][9]. - **Investment Focus**: Effective investments are anticipated in water conservancy, energy, municipal infrastructure, and core technology sectors such as AI, biomedicine, and quantum communication. The green transition is expected to unlock consumption potential in areas like eco-tourism and energy-efficient appliances [1][11]. Industry-Specific Insights Home Appliance Sector - The home appliance industry is projected to experience a downturn in the second half of 2025 due to trade-in policies, but a recovery is expected in early 2026 as subsidies are renewed, leading to a replenishment cycle [1][12][13]. - **Sales Data**: By November 2025, air conditioner sales grew by approximately 2%, while refrigerator sales declined by about 1%. The overall industry saw a decline in the latter half of the year, particularly in Q4, where air conditioner sales dropped over 20% [12][13]. Fiscal Policy and Consumer Behavior - The fiscal reform is expected to shift focus from incremental taxation to more comprehensive measures, such as property and capital gains taxes, which will gradually influence overall household income and consumption [7][8]. - The effectiveness of subsidies is questioned, as they may lead to a crowding-out effect on autonomous consumption. For instance, a 300 billion yuan subsidy led to a 2.7 trillion yuan increase in retail sales, but the non-subsidy portion contributed negatively [6]. Investment Recommendations - **Home Appliances**: Companies like Midea, Haier, TCL, and Hisense are recommended for their strong domestic and international performance. The expectation is that these companies will benefit from the renewed subsidy policies in 2026 [15]. - **New Consumption Trends**: Focus on emerging brands in personal care and health products, as well as established brands with significant market barriers, such as Mao Geping and Shanghai Jahwa [18]. - **Health and Wellness Sector**: Companies like Xianle Health and Ximai Foods are highlighted for their growth potential in the health and wellness market, driven by the aging population and increasing health awareness [19][21]. Additional Insights - **Transportation Sector**: The aviation industry is expected to benefit directly from increased demand, while the shipping industry will see indirect benefits from heightened domestic trade activities [28]. - **Agricultural Sector**: Recommendations include focusing on the pet industry and functional ingredients, with companies like Zhongchong and Bailong Chuangyuan showing strong growth potential [31]. Conclusion - The overall sentiment is optimistic regarding the expansion of domestic demand, with significant investment opportunities across various sectors, particularly in health, home appliances, and new consumption trends. The emphasis on increasing resident income and effective fiscal reforms will be crucial in driving this growth [26][27].

兴业证券股份有限公司 关于青木科技股份有限公司 2025 年持续督导培训情况报告 为了进一步提高青木科技股份有限公司（以下简称"青木科技"或"公司"） 上市后规范运作水平，促进公司的健康发展，兴业证券股份有限公司（以下简称 "兴业证券"或"保荐机构"）特对青木科技控股股东、实际控制人、董事和高 级管理人员等进行了相关培训。现将培训情况汇报如下： | 培训时间 | 年 日 12 12 | 月 2025 | | --- | --- | --- | | 培训地点 | 线上培训 | | | 培训主题 | 上市公司治理准则、上市公司信息披露管理办法及募集资金相关规则 | | | | 等持续监管规则 | | | 培训讲师 | 保荐代表人 林悦 | | | 参训人员 | 控股股东、实际控制人、董事和高级管理人员等 | | 一、培训主要内容 本次培训内容主要介绍 2025 年以来新修订法规主要内容，并重点介绍《上 市公司治理准则》《上市公司信息披露管理办法》和募集资金新规的修订内容及 对上市公司的影响。本次培训重点结合最新规定及相关案例，对相关内容进行了 讲解，同时对相关人员的提问进行解答和交流。 二、培训效果情况 通过本次 ...

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, despite recent underperformance compared to the market [4][5]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance, with the Shenwan Beauty Care Index declining by 2.0% from November 28 to December 5, 2025, underperforming the market [4][5]. - Douyin's performance in November met expectations, with domestic brands preparing actively for the upcoming Double 12 sales event, indicating a strong competitive landscape for domestic products [4][10]. - The report highlights the leading market share of Minoxidil products, particularly from Mandi International, which has established itself as a top brand in the hair growth sector [11][12]. Summary by Sections Industry Performance - The Shenwan Cosmetics Index fell by 2.2%, while the Shenwan Personal Care Index also dropped by 2.0%, both underperforming against the Shenwan A Index [4][5]. - The top-performing stocks in the sector included Juzhibio (+5.9%) and Hongmian Co. (+3.5%), while the worst performers were Kelao Co. (-7.6%) and Baiya Co. (-4.8%) [6]. Key Market Developments - Mandi International has dominated the Minoxidil market, achieving a revenue growth from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, with a CAGR of 21.7% [12][13]. - The company has maintained a leading position in the market for ten consecutive years, with a market share of about 57% in the hair loss treatment sector and 71% in the Minoxidil product market as of 2024 [12][14]. E-commerce Insights - In November 2025, Douyin's domestic brand GMV showed significant growth, with brands like Han Shu and New Page experiencing double-digit increases [15][18]. - The overall retail sales of cosmetics in October 2025 grew by 9.6%, driven by the Double 11 shopping festival, indicating a robust recovery in consumer spending [18][20]. Company Announcements - Lin Qingxuan updated its IPO prospectus for the Hong Kong market, reporting a revenue of 1.052 billion yuan in the first half of 2025, a year-on-year increase of 98.3% [22][19]. - The company plans to expand its research and development team and explore international markets in Southeast Asia [22][19]. Market Trends - The Chinese consumer healthcare market is projected to grow from 9.313 billion yuan in 2018 to 16.420 billion yuan in 2024, with a CAGR of 9.9% [13]. - The report emphasizes the increasing market share of domestic brands in the skincare sector, with a notable rise in the competitive landscape against international brands [24].

中国总代理权（持股100%）： Vitalis 旗下Noromega 品牌在国内的总代理权。①挪威高端膳食补充剂品 牌，核心主打北极圈原生态天然原料，核心成分包含海豹油、鱼油、虾青素、辅酶Q10 等，②王牌单品 海豹油胶囊、虾青素胶囊，已连续五年蝉联天猫国际海豹油、虾青素类目的 Top1。 投资建议：本次重磅收购Vitalis，获得品牌全供应链及中国区的总代理权，品牌孵化管理业务再进一 步；当前品牌孵化管理业务已有覆盖女性护理＆保健品的多品牌矩阵，同时公司已与Dermofarm 正式签 署战略合作协议，关注后续双方有望进一步深化合作带来的增量变化。同时公司作为AI首批生态Agent 合作服务商重点投入已有成效落地，AI+应用有望助力公司提升份额＆降本增效提升盈利水平，关注公 司品牌管理孵化与AI+应用双轮驱动经营拐点的机会。 风险提示：新品牌放量不及预期；消费复苏不及预期；行业竞争加剧 事件：公司公告全资子公司青木新加坡拟合计斥资3 亿挪威克朗（约2.12 亿元人民币）收购Vitalis 65.83%股权并成为其控股股东：以1.5亿NOK 收购股权49.07%及1.5 亿NOK 认购新股32.8%方式；股权 ...

Group 1: Industry Changes - Aoki Technology Holdings is acquiring 65.83% of Norway's Vitalis for approximately 212 million RMB (30 million NOK), with the deal expected to close in 2026. Post-acquisition, Aoki will gain exclusive distribution rights for Vitalis's high-end dietary supplement brand Noromega in China, which has been a top seller on Tmall International for five consecutive years. Vitalis has committed to a net profit of no less than 22 million RMB in 2025, with a target of at least 35% year-on-year growth in 2027 and 2028 [1] - Jinbo Bio has received a registration certificate for its recombinant collagen injection in the Philippines, marking another international expansion after obtaining a similar certificate in Vietnam. The product is aimed at facial dermal filling for dynamic wrinkles and is classified as a high-risk D class medical device. This expansion aligns with the company's growth strategy and its aim to enter the "collagen+" era [2] - Longfeng Group has submitted a listing application to the Hong Kong Stock Exchange, potentially becoming the first "Hong Kong stock cosmetics store." The group operates 29 stores in Hong Kong and has over 600 suppliers, with revenue projected to grow from 1.094 billion HKD to 2.461 billion HKD from FY2023 to FY2025, reflecting a compound annual growth rate of 50% [3] Group 2: Market Insights - The overall consumer sector is currently in a valuation trough, with opportunities for recovery as the market adjusts. Key areas of focus include personal care and health sectors, particularly in health supplements and women's care, with companies like Aoki Technology and Weiyu Chen being highlighted [4] - The Double 11 shopping festival is expected to see intensified competition, with a focus on strong alpha beauty brands such as Mao Ge Ping and Shangmei Shares [4] - There is a potential turning point for upstream performance, with some upstream companies showing signs of recovery due to improved downstream demand and capacity adjustments. Companies like Qingsong Shares and Jiega Shares are under observation [4] - The AI+ operational model is gaining traction, with Alibaba's launch of the Qianwen AI application expected to deepen its integration into e-commerce, presenting investment opportunities in companies like Yiwang Yichuang and Aoki Technology [4] - The medical aesthetics sector is being closely monitored for new product commercialization, with companies like Ruiri Medical Technology and Jinbo Bio being of particular interest [4] Group 3: Retail Sector Updates - Chow Tai Fook reported a revenue of 38.99 billion HKD for FY26H1, a decrease of 1.1%, while operating profit increased by 0.7% to 6.82 billion HKD [5] - Luk Fook Holdings saw a revenue increase of 25.6% to 6.84 billion HKD for FY26H1, with operating profit rising by 45.4% to 780 million HKD [5] - Alibaba's FY26Q2 revenue reached 247.8 billion HKD, up 4.8%, but net profit dropped by 52.1% to 20.99 billion HKD. The strong performance of Alibaba Cloud and the launch of the C-end AI application are noteworthy [6] - Baozun E-commerce reported a revenue growth of 4.8% to 2.16 billion HKD, but its net loss expanded to 107 million HKD [7] - The Ministry of Industry and Information Technology, along with five other departments, released a plan to enhance the adaptability of consumer goods supply and demand, aiming for significant improvements by 2027 [8]

Group 1: Economic Policy Outlook - The fiscal policy for 2025 is characterized by increased intensity, advanced timing, and enhanced flexibility, reflecting a strong intent to support the economy. The fiscal financing scale is expected to reach a historical high of 14.36 trillion yuan, accounting for 10.2% of GDP [2][8] - In the first three quarters of 2025, broad fiscal expenditure is projected to grow by 7.9% year-on-year, indicating a high level of spending intensity [2][8] - The monetary policy is expected to return to a "moderately loose" tone, focusing on guiding expectations and improving transmission channels, with a cautious approach to interest rate cuts compared to 2024 [8] Group 2: Cosmetics and Aesthetic Medicine Industry - The international cosmetics and aesthetic medicine companies are experiencing a strategic adjustment in China, with signs of recovery in the market. The third quarter of 2025 shows a positive revenue growth trend in China, driven by promotional events [3][11] - Key recommendations for the cosmetics sector include companies with strong channel and brand matrices such as Maogeping, Shangmei, and Proya, while companies like Marubi and Huaxi Biological are expected to see marginal improvements in growth [3][11] - In the aesthetic medicine sector, companies with high R&D barriers and strong profitability are favored, with a focus on major product drivers and extensive product pipelines [3][11] Group 3: Kweichow Moutai (贵州茅台) - Kweichow Moutai maintains a buy rating with profit forecasts for 2025-2027 at 90.47 billion, 95.02 billion, and 101.53 billion yuan respectively, with corresponding PE ratios of 20x, 19x, and 18x [12][10] - The company emphasizes its strong brand barrier and excellent business model, which contribute to stable long-term profitability and high cash flow quality [12][10] - Moutai's strategy includes a focus on sustainable development and a commitment to not sacrificing long-term growth for short-term gains, with expectations for stable growth during the 14th Five-Year Plan period [13][10]

Investment Rating - The report maintains a positive outlook on the international cosmetics and medical beauty industry, indicating a recovery trend in the Chinese market and a cautious approach towards North America due to economic factors [2][3]. Core Insights - The global beauty market is projected to grow at a rate of 4.5% in 2024, a decline from the 8% growth seen in 2023, with significant regional disparities in performance [3][13]. - The Chinese market showed signs of recovery in Q3 2025, with major international brands reporting positive revenue growth after a period of decline [3][19]. - Companies like L'Oréal and Estée Lauder are adjusting their strategies to enhance their market presence in China, with Estée Lauder reporting an 8.6% revenue growth in Q3 2025 [3][47]. Summary by Sections Global Market Overview - The global beauty market is experiencing a slowdown, with North America showing signs of weakness while Europe outperforms other regions with a 7.5% growth [3][13]. - The North Asia market, particularly China, has faced a decline of 2%, marking it as the weakest among major beauty markets [3][13]. L'Oréal - L'Oréal's revenue growth for the first three quarters of 2025 is 1.2%, with a slight improvement in Q3 2025, indicating a recovery from previous declines [3][27]. - The company is focusing on acquisitions and enhancing its brand portfolio, particularly in the Chinese market, where it aims to leverage online channels [3][24]. Estée Lauder - Estée Lauder's Q3 2025 revenue growth reached 8.6%, marking a significant turnaround after four consecutive quarters of decline [3][47]. - The company is implementing a strategic overhaul to address previous challenges, including inventory issues and competition from local brands [3][47]. Shiseido - Shiseido reported an 8% revenue growth in the Chinese market for Q3 2025, although it continues to face macroeconomic challenges [3][19]. - The company is experiencing a K-shaped recovery, with its premium brands performing better than its main brand [3][19]. Investment Recommendations - The report recommends focusing on companies with strong channel and brand matrices, such as Mao Ge Ping and Shanghai Jahwa, as well as those expected to see marginal improvements in growth, like Marubi and Betaini [4][5]. - In the medical beauty sector, companies with high R&D barriers and strong profitability, such as Ai Meike, are highlighted as key investment opportunities [4][5].